“My wife had retinal detachment. Dr. did initial evaluation, Dr. performed surgery, skills impeccable, thorough and considerate. Staff top notch. Grateful!”
Branch Retinal Vein Occlusion: Causes, Symptoms, and Treatment
Who Is at Risk for BRVO?
BRVO is most common in people over the age of 50, and it is closely tied to conditions that affect the health of blood vessels throughout the body. Identifying your risk factors is an important step in both prevention and early detection.
As the body ages, blood vessels naturally lose flexibility. This stiffening makes arteriovenous crossings in the retina more vulnerable to compression, increasing the likelihood of a blockage. While BRVO can occur in younger adults, it becomes significantly more common with each decade after age 50.
Uncontrolled high blood pressure is the single most important systemic risk factor for BRVO. Elevated pressure damages artery walls and accelerates atherosclerosis, making it more likely that a retinal artery will compress a nearby vein. Keeping blood pressure well controlled is one of the most effective ways to protect the retinal blood vessels.
Diabetes mellitus damages small blood vessel walls and promotes abnormal clotting, both of which increase BRVO risk. When diabetes occurs alongside high blood pressure and high cholesterol, a cluster of conditions known as metabolic syndrome, the combined risk rises substantially. People with complications from both diabetes and hypertension face a particularly elevated risk.
Several additional conditions can raise the likelihood of developing BRVO. A retina specialist will often coordinate with your primary care team to evaluate and address these factors.
- High cholesterol or elevated triglycerides (hyperlipidemia)
- Being overweight or obese
- Blood clotting disorders (thrombophilia)
- Conditions that cause abnormally thick blood (hyperviscosity)
- Personal history of a vascular stroke
- Cardiovascular disease, including coronary artery disease
Recognizing the Symptoms
BRVO can present differently depending on which part of the retina is affected and whether the macula is involved. Knowing the warning signs helps ensure you seek care quickly, which matters greatly for outcomes.
The most recognizable symptom of BRVO is a sudden, painless change in part of your visual field. This may appear as blurring, distortion, or a darkened area. Some people notice it all at once, while others experience a gradual worsening over hours or days. When the macula is affected, central vision is impacted and the change is usually noticeable right away.
Some patients with BRVO notice new floaters, which appear as dark spots, lines, or drifting shapes in the vision. Floaters can occur when small amounts of blood from damaged retinal vessels leak into the vitreous, the clear gel that fills the inside of the eye. This symptom should not be dismissed, especially when it appears alongside any blurring or vision change.
Any sudden, unexplained change in vision warrants prompt attention. If you notice a sudden increase in floaters, flashes of light, a shadow or dark curtain across part of your vision, or a rapid loss of vision in one eye, contact a retina specialist or go to an emergency room immediately. Quick evaluation offers the best chance of preserving vision.
How BRVO Is Diagnosed
Accurate diagnosis of BRVO requires a thorough examination by a retina specialist using a combination of clinical evaluation and advanced retinal imaging. These tools help confirm the diagnosis, assess severity, and guide the most appropriate treatment plan.
A retina specialist will begin with a comprehensive dilated eye exam. Eye drops are used to widen the pupil, allowing a detailed view of the retina. During this examination, the specialist can identify signs of vein blockage including swollen vessels, areas of retinal bleeding, and fluid accumulation in the retinal layers.
OCT is a non-invasive imaging test that creates precise, cross-sectional images of the retina. It allows a retina specialist to measure the exact thickness of the macula and detect even small amounts of fluid or swelling. OCT is used at both the initial visit and at follow-up appointments to track treatment response over time.
In this test, a small amount of contrast dye is injected into a vein in the arm. As the dye circulates through the retinal blood vessels, a specialized camera captures a rapid series of images. This allows the retina specialist to identify exactly where the blockage is, where fluid is leaking, whether any areas of the retina are ischemic, and whether abnormal new blood vessels have begun to grow.
Depending on clinical findings, additional imaging may be used to get a more complete picture of retinal health. OCT angiography provides detailed views of the retinal blood vessel network without dye injection. Wide-field imaging captures a broader view of the retina to identify areas of poor blood flow outside the central zone. B-scan ultrasound may be used when the retina cannot be fully visualized through standard examination.
Treatment Options for BRVO
Treatment for BRVO is focused on reducing macular swelling, preserving vision, and preventing complications such as abnormal vessel growth. The right approach depends on the severity of the condition and how your eye responds over time.
The primary treatment for macular edema caused by BRVO is intravitreal injection of anti-VEGF medication. Anti-VEGF (anti-vascular endothelial growth factor) drugs block a protein that drives abnormal blood vessel growth and fluid leakage in the retina. By reducing VEGF activity, these injections decrease macula swelling and can meaningfully improve vision.
Several anti-VEGF medications are used in the treatment of BRVO, including Avastin (bevacizumab), Lucentis (ranibizumab), Eylea (aflibercept), and Vabysmo (faricimab). The choice of medication and dosing schedule is determined by your retina specialist based on your individual response and clinical findings. Some of these agents allow for extended intervals between injections as the condition stabilizes.
Because macular edema tends to return after the medication wears off, anti-VEGF injections are typically given on a regular schedule. Your retina specialist will use OCT imaging at each visit to measure macular swelling and adjust your treatment interval accordingly. Some patients require monthly injections for an extended period, while others may transition to longer intervals as the condition stabilizes. Consistent follow-through with the recommended schedule is important for preserving the vision improvements achieved.
For patients who do not respond adequately to anti-VEGF therapy, a corticosteroid implant may be considered. The Ozurdex implant (dexamethasone) is a small device placed inside the eye that slowly releases steroid medication over several months. Steroid treatments carry risks including elevated eye pressure and accelerated cataract formation, so your retina specialist will carefully weigh the potential benefits against these risks before recommending this approach.
In select cases involving persistent inflammation or specific clinical presentations, a longer-acting steroid implant such as Iluvien (fluocinolone acetonide) may also be considered.
Focal laser photocoagulation uses a carefully targeted laser to seal leaking blood vessels around the macula and reduce fluid buildup. While anti-VEGF injections have become the preferred first-line treatment, laser therapy remains a useful option in certain clinical situations. Your retina specialist will advise whether laser treatment is appropriate for your specific case.
When BRVO leads to ischemia and the growth of abnormal new blood vessels on the retinal surface, scatter laser photocoagulation (also called panretinal photocoagulation or PRP) may be necessary. This procedure applies a pattern of laser treatments to the peripheral retina to reduce the oxygen demand driving abnormal vessel growth. Treating this complication early significantly reduces the risk of bleeding and other serious consequences.
What to Expect During and After Treatment
Many patients have questions about what intravitreal injections feel like and what recovery involves. Understanding the process can help reduce anxiety and make it easier to stay consistent with your care plan.
Intravitreal injections are performed in the retina specialist's office and typically take only a few minutes. The eye is first numbed with anesthetic drops, and the area around the eye is cleaned with an antiseptic solution. A very fine needle is then used to deliver the medication into the vitreous cavity at the back of the eye. Most patients feel only mild pressure or brief discomfort during the procedure.
Following an injection, it is common to notice temporary blurred vision, mild redness, or a gritty sensation in the eye. These effects typically resolve within one to two days. Your retina specialist will schedule follow-up visits, usually every four to eight weeks in the initial phase, to evaluate your retina with OCT imaging and determine whether additional treatment is needed.
Visual outcomes after BRVO vary from person to person and depend on factors including how much of the retina was affected, whether the macula sustained lasting damage, and how quickly treatment was started. Many patients experience meaningful improvement in vision with consistent anti-VEGF treatment, particularly when therapy begins early. Some degree of permanent visual change is possible if significant nerve cell damage occurred before treatment was initiated.
Living Well With BRVO
Managing BRVO is not limited to what happens in the clinic. The steps you take every day to support your overall health and monitor your vision play a meaningful role in your long-term outcome.
Because BRVO is so closely linked to systemic vascular health, managing contributing conditions is a core part of your care. Work with your primary care physician to keep blood pressure, blood sugar, and cholesterol levels within healthy ranges. Maintaining a healthy weight and avoiding smoking also support the health of retinal blood vessels over time.
Between clinic visits, pay attention to any new or worsening changes in your vision. An Amsler grid, a simple paper chart with a grid pattern, can help you detect new areas of distortion or blank spots in your central vision. Your retina specialist may provide one and show you how to use it as part of a daily monitoring routine. Any sudden change should prompt a prompt call to our office rather than waiting for a scheduled appointment.
A diagnosis that affects your vision can bring real emotional challenges. It is entirely normal to feel anxious or frustrated, especially when ongoing treatment is required. Talking with family, trusted friends, or a counselor can help. If vision remains affected despite treatment, low vision aids such as magnifying devices and improved lighting can make everyday tasks like reading and cooking more manageable.
Frequently Asked Questions
Here are answers to common questions patients ask about BRVO, with practical guidance to help you navigate diagnosis, treatment, and day-to-day life.
Yes. Having BRVO in one eye raises the risk of a future vein occlusion in either eye. The underlying conditions that cause BRVO, including high blood pressure and atherosclerosis, affect both eyes simultaneously. This is why managing systemic risk factors is so important even after successful treatment. Regular follow-up with a retina specialist allows for early detection if a new blockage begins to develop.
The number of injections varies considerably from one patient to the next. Some people need monthly treatment for the first year, while others may transition to extended intervals relatively quickly as their macula stabilizes. There is no universal endpoint. Your retina specialist will assess macular swelling at each visit using OCT imaging and adjust your schedule accordingly. The goal is always to use the fewest injections necessary to keep the macula dry and vision stable.
Complete recovery to pre-BRVO vision is not guaranteed and depends on several factors, including how quickly treatment began, how much of the retina was damaged, and whether the macula sustained lasting injury. Many patients do experience meaningful improvement, particularly when treatment starts early. Even when full recovery is not possible, consistent treatment can preserve the vision that remains and prevent further loss.
Whether you can safely drive depends on the extent of your vision loss and which eye is affected. If central vision in your dominant eye is significantly reduced, driving may not be safe, and this is something to discuss honestly with your retina specialist. Immediately after an injection, temporary blurring is common and you should plan to have someone drive you home. Work tasks that rely heavily on fine visual detail may need temporary adjustments depending on your level of vision.
While no approach eliminates the risk entirely, managing the conditions linked to blood vessel damage can reduce it significantly. Controlling blood pressure is the most impactful step. Keeping blood sugar and cholesterol in a healthy range, maintaining a healthy weight, exercising regularly, and not smoking all contribute to healthier retinal vessels. Routine dilated eye exams allow a retina specialist to detect early warning signs before significant vision loss occurs.
Do not wait for your next scheduled visit if you notice a sudden increase in floaters, new flashes of light, a shadow or dark area spreading across your vision, or a significant drop in vision in the affected eye. These changes can signal a new blockage, a surge in macular swelling, or the development of a complication that needs prompt evaluation. Contact our office as soon as possible, or go to an emergency room if you cannot reach us quickly.
Expert Retinal Care on the Delmarva Peninsula
At Atlantic Retina Center, our team of fellowship-trained, ABO board-certified retina specialists has dedicated our practice exclusively to the retina, vitreous, and macula. We offer the full range of diagnostic imaging and treatment options for BRVO and related retinal conditions, and we take the time to build a treatment plan tailored to your specific situation. If you have been diagnosed with branch retinal vein occlusion, or if you are experiencing sudden changes in your vision, we encourage you to contact our practice and schedule an evaluation with one of our retina specialists.